Therabene Appoints Oscar L. Kashala, M.D., Ph.D., D.Sc., as President and to Board of DirectorsSeasoned oncology physician-scientist and biopharmaceutical executive will continue to serve as Chief Medical OfficerLeadership appointment reinforces Therabene's commitment to advancing its targeted protein degradation platform and lead CDK9 degrader, TB-008
